GlassScriptPhysician profile
Michael A Berke
NPI 1578975082
$242,308.83
in general payments reported to CMS, 2019-2025
23 companies · $57K in 2025
The $57K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27K · 2022: $50K · 2023: $51K · 2024: $58K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $134K · Travel and Lodging: $24K · Food and Beverage: $6,813 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $133,882.99 |
| Travel and Lodging | $24,292.12 |
| Food and Beverage | $6,812.72 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $184,722.21 | 2021-2025 | Stratafix, Dermabond Prineo, Evarrest |
| Ethicon US, LLC | $55,074.76 | 2021-2025 | Stratafix, Prolene, Dermabond Prineo |
| Medtronic, INC. | $770.97 | 2022-2024 | Interstim |
| Getinge USA Sales, LLC | $349.22 | 2022-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Cardiohelp |
| Teleflex LLC | $344.49 | 2024 | Urolift |
| Ethicon INC. | $200.00 | 2021 | |
| Abbvie INC. | $147.91 | 2022-2023 | |
| Endo USA, INC. | $90.25 | 2024 | Aveed, Xiaflex |
| Abbott Laboratories | $88.30 | 2024-2025 | Epic, Esprit, Diamondback Peripheral |
| Antares Pharma, INC. | $79.48 | 2024 | Xyosted |
| Sumitomo Pharma America, INC. | $76.14 | 2024 | Orgovyx |
| Edwards Lifesciences Corporation | $67.42 | 2022-2025 | Pascal |
| Bayer Healthcare Pharmaceuticals INC. | $44.94 | 2024-2025 | |
| Abc Home Medical Supply, INC. | $44.60 | 2024 | |
| Merck Sharp & Dohme LLC | $32.57 | 2024 | Welireg, Keytruda |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $29.01 | 2024 | |
| Dendreon Pharmaceuticals LLC | $27.30 | 2024 | Provenge |
| Janssen Biotech, INC. | $27.29 | 2024 | Erleada, Akeega |
| Atricure, INC. | $20.24 | 2022 | |
| Pfizer INC. | $19.98 | 2024 | |
| Coloplast Corp | $19.21 | 2024 | |
| Kci USA, INC. | $18.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Berke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.